1. Home
  2. KRNY vs TBPH Comparison

KRNY vs TBPH Comparison

Compare KRNY & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNY
  • TBPH
  • Stock Information
  • Founded
  • KRNY 1884
  • TBPH 2013
  • Country
  • KRNY United States
  • TBPH United States
  • Employees
  • KRNY N/A
  • TBPH N/A
  • Industry
  • KRNY Savings Institutions
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • KRNY Finance
  • TBPH Health Care
  • Exchange
  • KRNY Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • KRNY 436.9M
  • TBPH 485.8M
  • IPO Year
  • KRNY 2005
  • TBPH N/A
  • Fundamental
  • Price
  • KRNY $7.32
  • TBPH $9.15
  • Analyst Decision
  • KRNY Buy
  • TBPH Buy
  • Analyst Count
  • KRNY 2
  • TBPH 4
  • Target Price
  • KRNY $7.75
  • TBPH $13.75
  • AVG Volume (30 Days)
  • KRNY 349.4K
  • TBPH 166.7K
  • Earning Date
  • KRNY 01-30-2025
  • TBPH 02-24-2025
  • Dividend Yield
  • KRNY 6.09%
  • TBPH N/A
  • EPS Growth
  • KRNY N/A
  • TBPH N/A
  • EPS
  • KRNY N/A
  • TBPH N/A
  • Revenue
  • KRNY $128,413,999.00
  • TBPH $63,192,000.00
  • Revenue This Year
  • KRNY N/A
  • TBPH $11.41
  • Revenue Next Year
  • KRNY $28.55
  • TBPH $37.36
  • P/E Ratio
  • KRNY N/A
  • TBPH N/A
  • Revenue Growth
  • KRNY N/A
  • TBPH 15.93
  • 52 Week Low
  • KRNY $5.28
  • TBPH $7.44
  • 52 Week High
  • KRNY $8.59
  • TBPH $10.44
  • Technical
  • Relative Strength Index (RSI)
  • KRNY 50.99
  • TBPH 49.84
  • Support Level
  • KRNY $7.10
  • TBPH $8.35
  • Resistance Level
  • KRNY $7.36
  • TBPH $8.86
  • Average True Range (ATR)
  • KRNY 0.24
  • TBPH 0.29
  • MACD
  • KRNY 0.06
  • TBPH -0.05
  • Stochastic Oscillator
  • KRNY 90.59
  • TBPH 58.39

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: